Corbus Pharmaceuticals
Focus: Corbus Pharmaceuticals is a specialty biotech focused on orphan inflammatory-fibrotic diseases with a pipeline spanning immunology, neurology, and rare diseases. Headquartered in Norwood, MA, the company operates at mid-cap biotech scale with a lean active job count of 5 roles.
Profile data last refreshed 15h ago · AI intelligence enriched 2w ago
Open Jobs
3+1 this month
Stable — net +1 jobs in 30d
3 added, 2 removed. Backfill posture.
Should You Work at Corbus Pharmaceuticals?
AI assessmentA specialized rare-disease biotech with a solid clinical pipeline and recent leadership upgrade, suitable for specialists seeking deep immunology/fibrotic disease expertise but risky for those prioritizing job security or rapid advancement in a growing organization.
Why Work Here
- Deep pipeline focus on rare/orphan diseases (9 active trials across Phase 1–3) with multiple shots on goal in immunology and fibrotic conditions, reducing single-program risk
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
PHASE_1
Clinical Trials (1)
NCT07310901A 2-part, Phase 1b Clinical Study Designed to Evaluate the Safety, PK, and Efficacy of CRB-913 in Participants With Obesity
Phase 1Help build intelligence for Corbus Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.